gsk2586881
Recombinant proteinexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2012 (NCT01597635)
Timeline
Indications
Mechanism of action
- AngiotensinogenSupplementation
AGT supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- gsk2586881
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03177603 | Phase 2 | Aug 7, 2017 | GlaxoSmithKline |
| NCT03000686 | Phase 1 | May 17, 2017 | GlaxoSmithKline |
| NCT01597635 | Phase 2 | Sep 1, 2012 | GlaxoSmithKline |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 3 | 3 | 2 | 2012 |
1 organizations
Page 1 / 1